138 related articles for article (PubMed ID: 22298861)
1. Assessment of substantia nigra echogenicity in German and Filipino populations using a portable ultrasound system.
Go CL; Frenzel A; Rosales RL; Lee LV; Benecke R; Dressler D; Walter U
J Ultrasound Med; 2012 Feb; 31(2):191-6. PubMed ID: 22298861
[TBL] [Abstract][Full Text] [Related]
2. Sonography for diagnosis of Parkinson disease-from theory to practice: a study on 300 participants.
Alonso-Cánovas A; López-Sendón JL; Buisán J; deFelipe-Mimbrera A; Guillán M; García-Barragán N; Corral I; Matute-Lozano MC; Masjuan J; Martínez-Castrillo JC; Walter U
J Ultrasound Med; 2014 Dec; 33(12):2069-74. PubMed ID: 25425362
[TBL] [Abstract][Full Text] [Related]
3. Substantia Nigra Hyperechogenicity: Validation of Transcranial Sonography for Parkinson Disease Diagnosis in a Large Estonian Cohort.
Toomsoo T; Liepelt-Scarfone I; Kerner R; Kadastik-Eerme L; Asser T; Rubanovits I; Berg D; Taba P
J Ultrasound Med; 2016 Jan; 35(1):17-23. PubMed ID: 26589647
[TBL] [Abstract][Full Text] [Related]
4. Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder.
Iranzo A; Stockner H; Serradell M; Seppi K; Valldeoriola F; Frauscher B; Molinuevo JL; Vilaseca I; Mitterling T; Gaig C; Vilas D; Santamaria J; Högl B; Tolosa E; Poewe W
Mov Disord; 2014 Dec; 29(14):1774-80. PubMed ID: 25384461
[TBL] [Abstract][Full Text] [Related]
5. Hyperechogenicity of the substantia nigra in Parkinson's disease.
Ressner P; Skoloudík D; Hlustík P; Kanovský P
J Neuroimaging; 2007 Apr; 17(2):164-7. PubMed ID: 17441838
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the substantia nigra by means of transcranial ultrasound imaging].
Vivo-Orti MN; Tembl JI; Sastre-Bataller I; Vazquez-Costa JF; Sahuquillo P; Burguera JA
Rev Neurol; 2013 Mar; 56(5):268-74. PubMed ID: 23440754
[TBL] [Abstract][Full Text] [Related]
7. Sonographic alteration of substantia nigra is related to parkinsonism-predominant course of X-linked dystonia-parkinsonism.
Walter U; Rosales R; Rocco A; Westenberger A; Domingo A; Go CL; Brüggemann N; Klein C; Lee LV; Dressler D
Parkinsonism Relat Disord; 2017 Apr; 37():43-49. PubMed ID: 28094105
[TBL] [Abstract][Full Text] [Related]
8. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease.
Walter U; Dressler D; Probst T; Wolters A; Abu-Mugheisib M; Wittstock M; Benecke R
Arch Neurol; 2007 Nov; 64(11):1635-40. PubMed ID: 17998447
[TBL] [Abstract][Full Text] [Related]
9. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography.
Becker G; Seufert J; Bogdahn U; Reichmann H; Reiners K
Neurology; 1995 Jan; 45(1):182-4. PubMed ID: 7824114
[TBL] [Abstract][Full Text] [Related]
10. Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome.
Schmidauer C; Sojer M; Seppi K; Stockner H; Högl B; Biedermann B; Brandauer E; Peralta CM; Wenning GK; Poewe W
Ann Neurol; 2005 Oct; 58(4):630-4. PubMed ID: 16037973
[TBL] [Abstract][Full Text] [Related]
11. [Transcranial sonography for the diagnosis of Parkinson disease].
Venegas F P; Miranda G G; Silva C MC
Rev Med Chil; 2011 Jan; 139(1):54-9. PubMed ID: 21526317
[TBL] [Abstract][Full Text] [Related]
12. The measuring of substantia nigra hyperechogenicity in an Italian cohort of Parkinson disease patients: a case/control study (NOBIS Study).
Prati P; Bignamini A; Coppo L; Naldi A; Comi C; Cantello R; Gusmaroli G; Walter U
J Neural Transm (Vienna); 2017 Jul; 124(7):869-879. PubMed ID: 28451942
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of transcranial sonography signal changes in the human substantia nigra.
Double KL; Todd G; Duma SR
Int Rev Neurobiol; 2010; 90():107-20. PubMed ID: 20692497
[TBL] [Abstract][Full Text] [Related]
14. How to measure substantia nigra hyperechogenicity in Parkinson disease: detailed guide with video.
Walter U
J Ultrasound Med; 2013 Oct; 32(10):1837-43. PubMed ID: 24065265
[TBL] [Abstract][Full Text] [Related]
15. Transcranial sonography of the substantia nigra: digital image analysis.
Skoloudík D; Jelínková M; Blahuta J; Cermák P; Soukup T; Bártová P; Langová K; Herzig R
AJNR Am J Neuroradiol; 2014 Dec; 35(12):2273-8. PubMed ID: 25059698
[TBL] [Abstract][Full Text] [Related]
16. Substantia nigra hyperechogenicity and Parkinson's disease risk in patients with essential tremor.
Sprenger FS; Wurster I; Seppi K; Stockner H; Scherfler C; Sojer M; Schmidauer C; Berg D; Poewe W
Mov Disord; 2016 Apr; 31(4):579-83. PubMed ID: 26893155
[TBL] [Abstract][Full Text] [Related]
17. Severity of restless legs syndrome is inversely correlated with echogenicity of the substantia nigra in different neurodegenerative movement disorders. a preliminary observation.
Pedroso JL; Bor-Seng-Shu E; Felicio AC; Braga-Neto P; Dutra LA; de Aquino CC; Ferraz HB; do Prado GF; Teixeira MJ; Barsottini OG
J Neurol Sci; 2012 Aug; 319(1-2):59-62. PubMed ID: 22632781
[TBL] [Abstract][Full Text] [Related]
18. Transcranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia.
Dong ZF; Wang CS; Zhang YC; Zhang Y; Sheng YJ; Hu H; Luo WF; Liu CF
Chin Med J (Engl); 2017 Oct; 130(19):2291-2295. PubMed ID: 28937033
[TBL] [Abstract][Full Text] [Related]
19. Structural abnormality of substantia nigra induced by methamphetamine abuse.
Rumpf JJ; Albers J; Fricke C; Mueller W; Classen J
Mov Disord; 2017 Dec; 32(12):1784-1788. PubMed ID: 29082542
[TBL] [Abstract][Full Text] [Related]
20. Substantia nigra echogenicity correlated with clinical features of Parkinson's disease.
Zhou HY; Sun Q; Tan YY; Hu YY; Zhan WW; Li DH; Wang Y; Xiao Q; Liu J; Chen SD
Parkinsonism Relat Disord; 2016 Mar; 24():28-33. PubMed ID: 26842545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
